Manuel Criollo-Orozco

ORCID: 0000-0001-6228-0405
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Virology and Viral Diseases
  • SARS-CoV-2 and COVID-19 Research
  • Virus-based gene therapy research
  • Animal Virus Infections Studies
  • Computational Drug Discovery Methods
  • Vector-Borne Animal Diseases
  • Animal Genetics and Reproduction
  • Herpesvirus Infections and Treatments
  • Transgenic Plants and Applications
  • Animal Disease Management and Epidemiology
  • Plant biochemistry and biosynthesis
  • vaccines and immunoinformatics approaches
  • Viral gastroenteritis research and epidemiology
  • Pharmacological Effects of Natural Compounds
  • COVID-19 Clinical Research Studies

Farvet (Peru)
2018-2024

University of Maryland, Baltimore County
2021

Abstract SARS-CoV-2 main protease is a common target for inhibition assays due to its high conservation among coronaviruses. Since flavonoids show antiviral activity, several in silico works have proposed them as potential inhibitors. Nonetheless, there reason doubt certain results given the lack of consideration flavonoid promiscuity or plasticity, usage short library sizes, absence control molecules and/or limitation methodology single site. Here, we report virtual screening study where...

10.1038/s41598-021-94951-6 article EN cc-by Scientific Reports 2021-07-29

In this study, we developed a new recombinant virus rHVT-F using Turkey herpesvirus (HVT) vector, expressing the fusion (F) protein of genotype XII Newcastle disease (NDV) circulating in Peru. We evaluated viral shedding and efficacy against NDV challenge specific pathogen-free (SPF) chickens. The F expression cassette was inserted unique long (UL) UL45-UL46 intergenic locus HVT genome by utilizing clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 gene-editing technology...

10.3390/v14040793 article EN cc-by Viruses 2022-04-11

COVID-19 pandemic has accelerated the development of vaccines against its etiologic agent, SARS-CoV-2. However, emergence new variants virus lead to generation alternatives improve current sub-unit in development. In present report, immunogenicity Spike RBD SARS-CoV-2 formulated with an oil-in-water emulsion and a water-in-oil squalene was evaluated mice hamsters. The protein expressed insect cells purified by chromatography until >95% purity. shown have appropriate folding as determined...

10.1371/journal.pone.0269823 article EN cc-by PLoS ONE 2022-08-23

Background and Aim: Gumboro disease is an economically crucial veterinary condition in chickens. It caused by the infectious bursal virus (IBDV). This consists of two serotype groups, which I strain pathogenic to For many years, development molecular techniques for either diagnostic purposes or surveillance appearance new strains has mainly focused on targeting VP2 genomic region. However, due constant necessity discrimination between already prevalent vaccine this virus, it becomes...

10.14202/vetworld.2024.2998-3004 article EN cc-by Veterinary World 2024-12-01
Manolo Fernández‐Díaz Katherine Calderón Aldo Rojas-Neyra Vikram N. Vakharia Ricardo Choque-Guevara and 85 more Ángela Montalván Astrid Poma-Acevedo Dora Rios-Matos Andrés Agurto-Arteaga María de Grecia Cauti-Mendoza Norma Pérez-Martínez Gisela Isasi-Rivas Luis Tataje‐Lavanda Yacory Sernaque-Aguilar Freddy Ygnacio Manuel Criollo-Orozco Edison Huaccachi-Gonzalez Elmer Delgado-Ccancce Doris Villanueva-Pérez Ricardo Montesinos Kristel Gutiérrez-Manchay Katherinne Pauyac-Antezana Ingrid Ramirez-Ortiz Stefany Quiñones-García Yudith Cauna-Orocollo Katherine Vallejos-Sánchez Angela Rios-Angulo Dennis Fernandez Mario I. Salguedo-Bohorquez Julio Ticona Manolo Fernández-Sanchez Eliana Icochea D. Luis A. Guevara-Sarmiento Mirko Zimic Andrés Agurto-Arteaga Ricardo Antiparra Manuel Ardiles-Reyes Katherine Calderón Yudith Cauna-Orocollo María de Grecia Cauti-Mendoza Naer Chipana-Flores Ricardo Choque-Guevara Xiomara Chunga-Girón Manuel Criollo-Orozco Lewis De La Cruz Elmer Delgado-Ccancce Nicolás E. Delgado-Pease Christian Elugo-Guevara Manolo Fernández‐Díaz Manolo Fernández- Sánchez Luis A. Guevara-Sarmiento Kristel Gutiérrez-Manchay Oscar Heredia-Almeyda Edison Huaccachi Gonzalez Pedro Huerta-Roque Eliana Icochea D. Gisela Isasi-Rivas Gabriel Jiménez-Avalos Romina A. Juscamaita-Bartra Abraham Licla-Inca Ángela Montalván Ricardo Montesinos Dennis Fernandez Adiana Ochoa-Ortiz Gustavo E. Olivos-Ramírez Erika Páucar-Montoro Katherinne Pauyac-Antezana Jose L. Perez-Martinez Norma Pérez-Martínez Astrid Poma-Acevedo Stefany Quiñones-García Ingrid Ramirez-Ortiz Daniel Ramos‐Sono Angela Rios-Angulo Dora Rios-Matos Aldo Rojas-Neyra Yomara K. Romero Mario I. Salguedo-Bohorquez Yacory Sernaque-Aguilar Patricia Sheen Luis F. Soto Luis Tataje‐Lavanda Julio Ticona Vikram N. Vakharia Katherine Vallejos-Sánchez A. Paula Vargas-Ruiz Doris Villanueva-Pérez Renzo G. Villena Freddy Ygnacio Mirko Zimic

Abstract The coronavirus disease-19 (COVID-19) pandemic has already claimed millions of lives and remains one the major catastrophes in recorded history. While mitigation control strategies provide short term solutions, vaccines play critical roles long disease. Recent emergence potentially vaccine-resistant novel variants necessitated testing deployment technologies that are safe, effective, stable, easy to administer, inexpensive produce. Here we developed three recombinant Newcastle...

10.1038/s41598-022-13560-z article EN cc-by Scientific Reports 2022-06-20

ABSTRACT The COVID-19 pandemic has claimed the lives of millions people worldwide and threatens to become an endemic problem, therefore need for as many types vaccines possible is high importance. Because doses required, it desirable that are not only safe effective, but also easy administer, store, inexpensive produce. Newcastle Disease Virus (NDV) responsible a respiratory disease in chickens. It no pathogenic homologue humans. NDV recognized oncolytic virus, its use humans oncological...

10.1101/2021.03.07.434276 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2021-03-08

Abstract COVID-19 pandemic has accelerated the development of vaccines against its etiologic agent, SARS-CoV-2. However, emergence new variants virus requires immunization strategies in addition to current approved for human administration. In present report, immunological and safety evaluation mice hamsters a subunit vaccine based on RBD sub-domain with two adjuvants oil origin is described. The protein was expressed insect cells purified by chromatography until >95% purity. shown have...

10.1101/2021.11.26.470043 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2021-11-30

El estudio tuvo por objetivo desarrollar una plataforma molecular para la cuantificación del virus de enfermedad Newcastle (NDV) a partir un sistema cultivo en huevos embrionados SPF. Primero se evaluaron cuatro pares cebadores que amplifican diferentes regiones genoma viral NDV codifican proteína nucleocápside (NP), matriz (M), fusión (F) y ARN polimerasa dependiente (L), con finalidad seleccionar el más conservado cual desarrolló basada transcripción reversa - reacción cadena convencional...

10.15381/rivep.v29i2.14523 article ES Revista de Investigaciones Veterinarias del Perú 2018-05-31

<title>Abstract</title> The COVID-19 pandemic has claimed the lives of millions people. Vaccination is a critical tool for control transmission; however, recent emergence potentially vaccine-resistant variants renders it important to have range vaccines types. It desirable that are safe, effective, easy administer and store, inexpensive produce. Newcastle disease virus (NDV), responsible respiratory in chickens, no pathogenic homologue humans. We developed two types NDV-vectored candidate...

10.21203/rs.3.rs-420780/v1 preprint EN cc-by Research Square (Research Square) 2021-04-27
Coming Soon ...